X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (242) 242
betahistine - therapeutic use (220) 220
female (158) 158
male (157) 157
middle aged (130) 130
adult (125) 125
betahistine (105) 105
index medicus (88) 88
meniere disease - drug therapy (88) 88
aged (84) 84
vertigo - drug therapy (75) 75
treatment outcome (67) 67
histamine agonists - therapeutic use (61) 61
vertigo (60) 60
pyridines - therapeutic use (57) 57
pharmacology & pharmacy (50) 50
otorhinolaryngology (48) 48
animals (47) 47
vasodilator agents - therapeutic use (45) 45
betahistine - administration & dosage (41) 41
double-blind method (40) 40
betahistine - pharmacology (38) 38
clinical trials as topic (32) 32
betahistine - adverse effects (30) 30
adolescent (29) 29
histamine (29) 29
double-blind (28) 28
meniere's disease (28) 28
time factors (26) 26
vertigo - etiology (26) 26
young adult (26) 26
neurosciences (24) 24
rats (24) 24
dizziness (22) 22
vestibular diseases - drug therapy (21) 21
medicine & public health (20) 20
olanzapine (20) 20
tinnitus - drug therapy (20) 20
amine oxidase - antagonists & inhibitors (19) 19
psychiatry (19) 19
tinnitus (19) 19
histamine agonists - pharmacology (18) 18
prospective studies (18) 18
cinnarizine - therapeutic use (17) 17
antipsychotic agents - adverse effects (15) 15
audiometry (15) 15
care and treatment (15) 15
clinical neurology (15) 15
ethylamines - therapeutic use (15) 15
histamine agonists - administration & dosage (15) 15
histamine h1 antagonists - therapeutic use (15) 15
surgery (15) 15
administration, oral (14) 14
aged, 80 and over (14) 14
betahistine dihydrochloride (14) 14
drug therapy (14) 14
drug therapy, combination (14) 14
follow-up studies (14) 14
menieres-disease (14) 14
weight gain - drug effects (14) 14
analysis (13) 13
brain (13) 13
drug evaluation (13) 13
food-intake (13) 13
medicine, general & internal (13) 13
meniere disease - complications (13) 13
meniere disease - diagnosis (13) 13
vasodilator agents - administration & dosage (13) 13
benzodiazepines - adverse effects (12) 12
compensation (12) 12
meniere disease - therapy (12) 12
placebos (12) 12
receptors (12) 12
severity of illness index (12) 12
vertigo - diagnosis (12) 12
vestibule, labyrinth - drug effects (12) 12
cat (11) 11
cinnarizine (11) 11
clinical trials (11) 11
combined modality therapy (11) 11
dose-response relationship, drug (11) 11
mechanisms (11) 11
ménière's disease (11) 11
patients (11) 11
postural balance - drug effects (11) 11
quality of life (11) 11
retrospective studies (11) 11
schizophrenia (11) 11
5579-84-0 (10) 10
5638-76-6 (10) 10
dimenhydrinate - therapeutic use (10) 10
dosage and administration (10) 10
drug combinations (10) 10
flunarizine - therapeutic use (10) 10
histamine agonists - adverse effects (10) 10
otorhinolaryngologic diseases (10) 10
pharmacology/toxicology (10) 10
rats, sprague-dawley (10) 10
vertigo - physiopathology (10) 10
vestibular function tests (10) 10
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (229) 229
Russian (30) 30
German (19) 19
Polish (8) 8
French (6) 6
Japanese (6) 6
Chinese (5) 5
Danish (3) 3
Dutch (3) 3
Spanish (3) 3
Ukrainian (2) 2
Bulgarian (1) 1
Italian (1) 1
Korean (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Psychopharmacology, ISSN 0033-3158, 4/2013, Volume 226, Issue 3, pp. 615 - 622
Combination treatment with reboxetine, a selective norepinephrine reuptake inhibitor, and betahistine, a histamine H1 receptor agonist/H3 antagonist, was... 
Antipsychotics | Reboxetine | Body mass index | Neurosciences | Biomedicine | Olanzapine | Pharmacology/Toxicology | Psychiatry | Betahistine | Weight gain | DEPRESSION | PSYCHIATRY | HISTAMINE H-1 | FOOD-INTAKE | BEHAVIOR | RATS | NEUROSCIENCES | PHARMACOLOGY & PHARMACY | RATING-SCALE | RECEPTORS | APPETITE | Antipsychotic Agents - adverse effects | Humans | Middle Aged | Betahistine - administration & dosage | Male | Histamine Agonists - administration & dosage | Young Adult | Antipsychotic Agents - therapeutic use | Adult | Female | Histamine Agonists - adverse effects | Weight Gain - drug effects | Histamine Agonists - therapeutic use | Morpholines - adverse effects | Morpholines - therapeutic use | Adrenergic Uptake Inhibitors - adverse effects | Adrenergic Uptake Inhibitors - therapeutic use | Double-Blind Method | Morpholines - administration & dosage | Betahistine - adverse effects | Treatment Outcome | Antipsychotic Agents - administration & dosage | Betahistine - therapeutic use | Adrenergic Uptake Inhibitors - administration & dosage | Benzodiazepines - administration & dosage | Benzodiazepines - adverse effects | Schizophrenia - drug therapy | Benzodiazepines - therapeutic use | Antipsychotic drugs | Schizophrenia | Dosage and administration | Research | Drug therapy | Appetite | olanzapine | Neuroleptics | Statistical analysis | Mental disorders | Body weight | Central nervous system | Clinical trials | Histamine H1 receptors | Norepinephrine | reboxetine
Journal Article
Psychopharmacology, ISSN 0033-3158, 12/2018, Volume 235, Issue 12, pp. 3545 - 3558
Journal Article
Journal Article
Journal of Psychopharmacology, ISSN 0269-8811, 9/2012, Volume 26, Issue 9, pp. 1271 - 1279
Olanzapine is effective at treating multiple domains of schizophrenia symptoms. However, it induces serious metabolic side effects. Antipsychotic drug’s... 
olanzapine | Antipsychotic | locomotor activity | betahistine | weight gain | food intake | PSYCHIATRY | FOOD-INTAKE | BEHAVIOR | SCHIZOPHRENIA | NEUROSCIENCES | ANTIPSYCHOTIC-DRUG TREATMENT | CLINICAL NEUROLOGY | BODY-WEIGHT | 2ND-GENERATION ANTIPSYCHOTICS | FEMALE RATS | PHARMACOLOGY & PHARMACY | ANIMAL-MODEL | PLACEBO-CONTROLLED TRIAL | RECEPTORS | Histamine H3 Antagonists - adverse effects | Appetite Depressants - adverse effects | Antipsychotic Agents - adverse effects | Motor Activity - drug effects | Hyperphagia - chemically induced | Appetite Depressants - therapeutic use | Drug Interactions | Exploratory Behavior - drug effects | Behavior, Animal - drug effects | Female | Histamine Agonists - adverse effects | Weight Gain - drug effects | Histamine H3 Antagonists - therapeutic use | Receptors, Histamine H1 - chemistry | Histamine Agonists - therapeutic use | Disease Models, Animal | Betahistine - adverse effects | Rats | Random Allocation | Rats, Sprague-Dawley | Feeding Behavior - drug effects | Animals | Hyperphagia - prevention & control | Betahistine - therapeutic use | Benzodiazepines - adverse effects | Complications and side effects | Care and treatment | Olanzapine | Analysis | Rattus | Physiological aspects | Weight gain | Obesity | Neuroleptics | Mental disorders | Clinical trials | Schizophrenia | Body weight gain | Feeding | Histamine H3 receptors | Histamine | Side effects | Food intake | Histamine H1 receptors | Locomotor activity
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2016, Volume 2016, Issue 6, p. CD010696
BACKGROUND: Vertigo is a symptom in which individuals experience a false sensation of movement. This type of dizziness is thought to originate in the inner ear... 
MEDICINE, GENERAL & INTERNAL | VESTIBULAR VERTIGO | PLACEBO | METAANALYSIS | COMMUNITY | DOUBLE-BLIND | DIZZINESS | PREVALENCE | DIHYDROCHLORIDE | EPIDEMIOLOGY | MENIERES-DISEASE | Vertigo - drug therapy | Betahistine - therapeutic use | Benign Paroxysmal Positional Vertigo - drug therapy | Humans | Betahistine - adverse effects | Randomized Controlled Trials as Topic
Journal Article
Journal Article